Company profile
Tg Therapeutics, Inc. Insider Trading
TGTXEvery SEC Form 4 insider trading filing for Tg Therapeutics, Inc. (TGTX) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001001316
- Filings
- 44
- Insiders
- 7
- Last filing
- 2026-09-10
Activity summary
Recent insider activity is bearish. Over the last 30 days, insiders net sold $275K across 1 transaction.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Tg Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.6M.
90 day insight
Over the last 90 days, Tg Therapeutics, Inc. insiders sold $275K across 1 transaction with no open-market purchases.
- Most active insider: Laurence N Charney with 4 transactions totaling $275K.
- Largest single sale: $275K by Laurence N Charney on Sep 10, 2026.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 50 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | Sagar Lonial | TGTX | Sale | 20,852 | $32.24 | $672K |
| Jun 13, 2025 | Yann Echelard | TGTX | Sale | 10,000 | $36.94 | $369K |
| Nov 11, 2024 | Laurence N Charney | TGTX | Sale | 25,000 | $30.20 | $755K |
| Nov 5, 2024 | Yann Echelard | TGTX | Sale | 20,000 | $24.48 | $490K |
| Jan 3, 2024 | Sean A Power | TGTX | Sale | 47,867 | $16.91 | $809K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TGTX" \
-H "X-Api-Key: $KEY"Get a keyTop insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of Tg Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →